Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization

被引:0
|
作者
Nikolas Friedrich
Emanuel Stiegeler
Matthias Glögl
Thomas Lemmin
Simon Hansen
Claus Kadelka
Yufan Wu
Patrick Ernst
Liridona Maliqi
Caio Foulkes
Mylène Morin
Mustafa Eroglu
Thomas Liechti
Branislav Ivan
Thomas Reinberg
Jonas V. Schaefer
Umut Karakus
Stephan Ursprung
Axel Mann
Peter Rusert
Roger D. Kouyos
John A. Robinson
Huldrych F. Günthard
Andreas Plückthun
Alexandra Trkola
机构
[1] University of Zurich (UZH),Institute of Medical Virology
[2] ETH Zurich,Department of Computer Science
[3] University of Zurich (UZH),Department of Biochemistry
[4] Iowa State University,Department of Mathematics
[5] University of Zurich (UZH),Department of Chemistry
[6] University Hospital Zurich (USZ),Division of Infectious Diseases and Hospital Epidemiology
[7] Roche Diagnostics GmbH,Euler Institute, Faculty of Biomedicine
[8] Università della Svizzera italiana (USI),Office Research and Teaching, Medical Faculty
[9] NGM Bio,Laboratory Medicine, Division of Clinical Chemistry
[10] 333 Oysterpoint Blvd,undefined
[11] Innovent Biologics Inc,undefined
[12] University of Zurich,undefined
[13] BeiGene Switzerland GmbH,undefined
[14] Janssen Vaccines AG,undefined
[15] ImmunoTechnology Section,undefined
[16] Vaccine Research Center,undefined
[17] NIAID,undefined
[18] NIH,undefined
[19] University Hospital Basel,undefined
[20] Novartis Institutes for BioMedical Research,undefined
[21] Chemical Biology & Therapeutics (CBT),undefined
[22] Novartis Pharma AG,undefined
[23] University of Cambridge School of Clinical Medicine,undefined
[24] Department of Radiology,undefined
[25] Roche Innovation Center Zurich,undefined
[26] Roche Pharmaceutical Research and Early Development (pRED),undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The V3 loop of the HIV-1 envelope (Env) protein elicits a vigorous, but largely non-neutralizing antibody response directed to the V3-crown, whereas rare broadly neutralizing antibodies (bnAbs) target the V3-base. Challenging this view, we present V3-crown directed broadly neutralizing Designed Ankyrin Repeat Proteins (bnDs) matching the breadth of V3-base bnAbs. While most bnAbs target prefusion Env, V3-crown bnDs bind open Env conformations triggered by CD4 engagement. BnDs achieve breadth by focusing on highly conserved residues that are accessible in two distinct V3 conformations, one of which resembles CCR5-bound V3. We further show that these V3-crown conformations can, in principle, be attacked by antibodies. Supporting this conclusion, analysis of antibody binding activity in the Swiss 4.5 K HIV-1 cohort (n = 4,281) revealed a co-evolution of V3-crown reactivities and neutralization breadth. Our results indicate a role of V3-crown responses and its conformational preferences in bnAb development to be considered in preventive and therapeutic approaches.
引用
收藏
相关论文
共 50 条
  • [31] Effect of Lysine to Arginine Mutagenesis in the V3 Loop of HIV-1 gp120 on Viral Entry Efficiency and Neutralization
    Schwalbe, Birco
    Schreiber, Michael
    PLOS ONE, 2015, 10 (03):
  • [32] Conserved structural elements in the V3 crown of HIV-1 gp120
    Jiang, Xunqing
    Burke, Valicia
    Totrov, Maxim
    Williams, Constance
    Cardozo, Timothy
    Gorny, Miroslaw K.
    Zolla-Pazner, Susan
    Kong, Xiang-Peng
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (08) : 955 - U63
  • [33] Sequence variability in the crown of the V3 loop of the HIV-1 envelope is clustered within a small 3D structural zone
    Almond, D.
    Kimura, T.
    Kong, X.
    Swetnam, J.
    Zolla-Pazner, S.
    Cardozo, T.
    RETROVIROLOGY, 2009, 6
  • [34] Immunofocusing using conformationally constrained V3 peptide immunogens improves HIV-1 neutralization
    Moseri, Adi
    Sinha, Eshu
    Zommer, Henni
    Arshava, Boris
    Naider, Fred
    Anglister, Jacob
    VACCINE, 2017, 35 (02) : 222 - 230
  • [35] 3D structure model for a peptide presenting the immunogenic crown of the HIV-1 GP120 V3 loop
    Andrianov, Alexander M.
    Teif, Vladimir B.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2007, 24 (06): : 769 - 769
  • [36] T=4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
    Zhang, Zhiqing
    He, Maozhou
    Bai, Shimeng
    Zhang, Feng
    Jiang, Jie
    Zheng, Qingbing
    Gao, Shuangquan
    Yan, Xiaodong
    Li, Shaowei
    Gu, Ying
    Xia, Ningshao
    VIRUSES-BASEL, 2018, 10 (12):
  • [37] IDENTIFICATION OF THE ENVELOPE V3 LOOP AS THE PRIMARY DETERMINANT OF CELL TROPISM IN HIV-1
    HWANG, SS
    BOYLE, TJ
    LYERLY, HK
    CULLEN, BR
    SCIENCE, 1991, 253 (5015) : 71 - 74
  • [38] HETEROGENEITY OF THE V3 LOOP OF THE HIV-1 ENVELOPE SEQUENTIALLY DERIVED FROM 3 ADULTS
    MCNEARNEY, T
    HORNICKOVA, Z
    ARENS, M
    MARKHAM, R
    RATNER, L
    CLINICAL RESEARCH, 1991, 39 (03): : A705 - A705
  • [39] V1 Loop Length Limits Neutralization of HIV-1 Clade C Primary Viruses by Broadly Neutralizing Antibodies Targeting the V3 Glycan
    Deshpande, Suprit
    Patil, Shilpa
    Kumar, Rajesh
    Hermanus, Tandile
    Murugavel, Kailapuri. G.
    Srikrishnan, Aylur K.
    Solomon, Suniti
    Morris, Lynn
    Bhattacharya, Jayanta
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 145 - 145
  • [40] Molecular design of a mimotope that preserves conserved structural elements of the HIV-1 V3 crown
    Jiang, X.
    Totrov, M.
    Sampson, J.
    Williams, C.
    Gorny, M. K.
    Zollla-Pazner, S.
    Kong, X.
    RETROVIROLOGY, 2009, 6